Gender-specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM

Hypertension

Volumn 31, Issue 4, 1998, Pages 896-899

  Freire, Maria Beatriz S ^b   Ji, Linong ^b   Onuma, Tomio ^b   Orban, Tihamer ^b   Warram, James H ^b   Krolewski, Andrzej S ^a  

^a JOSLIN DIABETES CENTER   (United States)

^b NONE

Author keywords

Angiotensinogen; Diabetes; Nephropathy; Polymorphism

Indexed keywords

ANGIOTENSINOGEN;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA DETERMINATION; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN CELL; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 0031924634     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.31.4.896     Document Type: Article

References (24)

1. Fogarty DG, Krolewski AS. Genetic susceptibility and the role of hypertension in diabetic nephropathy. Curr Opin Nephrol Hypertens. 1997;6:184-191.
2. Seaquist ER, Goetz FC, Rich SS, Barbosa J. Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med. 1989;320:1161-1165.
3. Borch-Johnsen K, Norgaard K, Hommel E, Mathiesen ER, Jensen JS, Deckert T, Parving HH. Is diabetic nephropathy an inherited complication? Kidney Int. 1992;41:719-722.
4. Quinn M, Angelico MC, Warram JH, Krolewski AS. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia. 1996;39:940-945.
5. Viberti GC, Keen H, Wiseman MJ. Raised arterial pressure in parents of proteinuric insulin dependent diabetics. BMJ. 1987;295:515-517.
6. Krolewski AS, Canessa M, Warram JH, Laffel L, Christlieb AR, Knowler WC, Rand LI. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med. 1988;318:140-145.
7. Stattin EL, Rudberg S, Dahlquist G. Hereditary risk determinants of micro- and macroalbuminuria in young IDDM patients. Diabetologia. 1996;39:299. Abstract.
8. Fagerudd J, Tarnow L, Jacobsen P, Stenman S, Nielsen FS, Pettersson-Fernholm K, Gronhagen-Riska C, Parving HH, Groop PH. Predisposition to hypertension and development of diabetic nephropathy in IDDM patients. J Am Soc Nephrol. 1997;8:110. Abstract.
9. Schmidt S, Ritz E. Genetics of the renin-angiotensin system and renal disease: a progress report. Curr Opin Nephrol Hypertens. 1997;6:146-151.
10. Cusi D. Genetic renal mechanisms of hypertension. Curr Opin Nephrol Hypertens. 1997;6:192-198.
11. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:169-180.
12. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, Cheng T, Ludwig EH, Sharma AM, Hata A, Jeunemaitre X, Lalouel JM. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest. 1997;99:1786-1797.
13. Fogarty DG, Harron JC, Hughes AE, Nevin NC, Doherty CC, Maxwell AP. A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes. 1996;45:1204-1208.
14. Doria A, Onuma T, Gearin G, Freire MBS, Warram JH, Krolewski AS. Angiotensinogen polymorphism M235T, hypertension, and nephropathy in insulin-dependent diabetes. Hypertension. 1996;27:1134-1139.
15. Rogus JJ, Moczulski D, Freire MBS, Yang Y, Warram JH, Krolewski AS. Diabetic nephropathy is associated with AGT polymorphism T235: results of a family-based study. Hypertension. 1998. In press.
16. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Richard S, Poirier O, Parving HH. Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy. Diabetes. 1996;45:367-369.
17. Schmidt S, Giebel R, Bergis KH, Strojek K, Grzeszczak W, Ganten D, Ritz E, Diabetic Nephropathy Study Group. Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy. Nephrol Dial Transplant. 1996;11:1755-1761.
18. Warram JH, Gearin G, Laffel L, Krolewski AS. Effect of duration of type 1 diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol. 1996;7:930-937.
19. Grubin CE, Daniels T, Toivola B, Landin-Olsson M, Hagopian WA, Li L, Karlsen AE, Boel E, Michelsen B, Lernmark A. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia. 1994;37:344-350.
20. Christie MR, Vohra G, Champagne D, Delovitch TL. Distinct antibody specificities to a 64-kD islet cell antigen in type 1 diabetes as revealed by trypsin treatment. J Exp Med. 1990;172:789-794.
21. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28: 1039-1057.
22. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
23. Breslow NE, Day NE. Statistical Methods in Cancer Research, I: The Analysis of Case-Control Studies. Lyon. France: International Agency for Research on Cancer; 1980:123-246.
24. Hopkins PN, Lifton RP, Hollenberg NK, Jeunemaitre X, Hallouin MC, Skuppin J, Williams CS, Dluhy RG, Lalouel JM, Williams RR, Williams GH. Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens. 1996;14:199-207.